Laura Lyman Rodriguez, Ph.D., is the Director of Genome Policy and National Engagement at Geisinger National Precision Health within the Geisinger Health System.

Her focus includes the following activities to support a patient-centered approach to genomic and precision medicine implementation:

• Providing policy and ethics leadership for developing a clinical genome sequencing pipeline within standard of care practices.
• Developing a stakeholder engagement portfolio to support and extend partnerships with patients, providers, and other health system entities

Prior to joining Geisinger in May 2019, Dr. Rodriguez spent more than 16 years at the National Human Genome Research Institute within the National Institutes of Health (NHGRI, NIH).

For the majority of her NHGRI tenure, she was the Director for the Division of Policy, Communications, and Education. Her responsibilities there included policy development related to NHGRI’s research initiatives, communication, and outreach activities. The goal of which to engage the public in genomic science and programs to prepare healthcare providers for the integration of genomic medicine into clinical care.

Dr. Rodriguez was also a primary leader for the development of NIH genomic data sharing policies and co-lead for their day-to-day oversight and implementation at the agency.

Before joining the NIH, Dr. Rodriguez spent time at the National Academy of Medicine, where she focused on the federal system for protecting human research participants, the Office of Public Affairs at the Federation of American Societies for Experimental Biology, and on Capitol Hill.

Dr. Rodriguez received her Bachelor of Science with honors in biology from Washington and Lee University and earned a doctorate in cell biology from Baylor College of Medicine.